-
1
-
-
0001413441
-
The marginal cost of public funds
-
Browning E.K. The marginal cost of public funds. Journal of Political Economy 84 2 (1976) 283-298
-
(1976)
Journal of Political Economy
, vol.84
, Issue.2
, pp. 283-298
-
-
Browning, E.K.1
-
2
-
-
0002257846
-
Patent expiration, entry, and competition in the US pharmaceutical industry
-
Caves R.E., Whinston M.D., et al. Patent expiration, entry, and competition in the US pharmaceutical industry. Brookings Papers on Economic Activity (1991) 1-48
-
(1991)
Brookings Papers on Economic Activity
, pp. 1-48
-
-
Caves, R.E.1
Whinston, M.D.2
-
3
-
-
0006144883
-
Does public insurance crowd out private insurance?
-
Cutler D.M., and Gruber J. Does public insurance crowd out private insurance?. Quarterly Journal of Economics 112 2 (1996) 391-430
-
(1996)
Quarterly Journal of Economics
, vol.112
, Issue.2
, pp. 391-430
-
-
Cutler, D.M.1
Gruber, J.2
-
5
-
-
33644870984
-
The distortionary effects of government procurement: evidence from medicaid prescription drug purchasing.
-
Duggan M., and Scott Morton F.M. The distortionary effects of government procurement: evidence from medicaid prescription drug purchasing. Quarterly Journal of Economics 121 1 (2006) 1-30
-
(2006)
Quarterly Journal of Economics
, vol.121
, Issue.1
, pp. 1-30
-
-
Duggan, M.1
Scott Morton, F.M.2
-
6
-
-
0041125784
-
Tax avoidance and the deadweight loss of the income tax.
-
Feldstein M. Tax avoidance and the deadweight loss of the income tax. Review of Economics and Statistics 81 4 (1999) 674-680
-
(1999)
Review of Economics and Statistics
, vol.81
, Issue.4
, pp. 674-680
-
-
Feldstein, M.1
-
7
-
-
38849203212
-
Should drug prices be negotiated under Part D of medicare? And if so, how?
-
Frank R.G., and Newhouse J.P. Should drug prices be negotiated under Part D of medicare? And if so, how?. Health Affairs 27 1 (2008) 33-43
-
(2008)
Health Affairs
, vol.27
, Issue.1
, pp. 33-43
-
-
Frank, R.G.1
Newhouse, J.P.2
-
9
-
-
33749343314
-
Benefit design and specialty drug use.
-
(Millwood)
-
Goldman D.P., Joyce G.F., et al. Benefit design and specialty drug use. Health Affairs 25 5 (2006) 1319-1331 (Millwood)
-
(2006)
Health Affairs
, vol.25
, Issue.5
, pp. 1319-1331
-
-
Goldman, D.P.1
Joyce, G.F.2
-
11
-
-
0009009362
-
Patent buyouts: a mechanism for encouraging innovation
-
Kremer M. Patent buyouts: a mechanism for encouraging innovation. Quarterly Journal of Economics 113 4 (1998) 1137-1167
-
(1998)
Quarterly Journal of Economics
, vol.113
, Issue.4
, pp. 1137-1167
-
-
Kremer, M.1
-
15
-
-
36849059199
-
The impact of Medicare Part D on prescription drug use by the elderly
-
Lichtenberg F.R., and Sun S.X. The impact of Medicare Part D on prescription drug use by the elderly. Health Affairs 26 6 (2007) 1735-1744
-
(2007)
Health Affairs
, vol.26
, Issue.6
, pp. 1735-1744
-
-
Lichtenberg, F.R.1
Sun, S.X.2
-
19
-
-
0031153344
-
The strategic response by pharmaceutical firms to the medicaid most-favored-customer rules
-
Scott Morton F. The strategic response by pharmaceutical firms to the medicaid most-favored-customer rules. Rand Journal of Economics 28 2 (1997) 269-290
-
(1997)
Rand Journal of Economics
, vol.28
, Issue.2
, pp. 269-290
-
-
Scott Morton, F.1
-
21
-
-
61549134614
-
The effect of pharmaceutical regulation on revenues
-
Sood N., de Vries H., et al. The effect of pharmaceutical regulation on revenues. Health Affairs 28 (1) (2009)
-
(2009)
Health Affairs 28 (1)
-
-
Sood, N.1
de Vries, H.2
|